AmerisourceBergen (ABC)

$179.97

up-down-arrow $5.01 (2.86%)

As on 29-Sep-2023 09:30EDT

Market cap

info icon

$36,150 Mln

Revenue (TTM)

info icon

$254,425 Mln

P/E Ratio

info icon

21.9

P/B Ratio

info icon

5.6

Div. Yield

info icon

1.1 %

AmerisourceBergen (ABC) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 179.33 High: 183.06

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $1,689 Mln

  • ROEROE information

    2.3 %

  • ROCEROCE information

    27.6 %

  • Industry P/EIndustry P/E information

    46.76

  • EV/EBITDAEV/EBITDA information

    11.4

  • Debt to EquityDebt to Equity information

    4.5

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    200,854,000

10 Years Aggregate

CFO

$22,171.29 Mln

EBITDA

$22,659.39 Mln

Net Profit

$4,770.68 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
AmerisourceBergen (ABC)
8.6 -0.2 -5.1 30.0 22.6 14.3 11.4
BSE Sensex*
-8.5 5.3 -5.9 -3.4 8.2 9.3 11.7
As on 29-Sep-2023  |  *As on 29-Apr-2026
Company
2022
2021
2020
2019
2018
2017
2016
AmerisourceBergen (ABC)
24.7 38.0 17.0 16.5 -17.5 19.5 -23.3
BSE Sensex
4.4 22.0 15.8 14.4 5.9 27.9 1.9
BSE Sensex
4.4 22.0 15.8 14.4 5.9 27.9 1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
AmerisourceBergen (ABC)
180.0 36,149.7 254,425.2 1,689.5 1.0 355.8 21.9 5.6
7.9 5,292.8 6,552.2 -530.2 -4.1 -9.2 -- 1.0
299.5 8,082.3 2,583.2 759.9 25.2 10.8 10.8 1.1
36.3 5,563.8 3,436.5 -8.6 2.2 -0.4 -- 2.2
119.6 7,074.2 507.4 -187.7 -36.2 -26.4 -- 10.8
83.6 5,490.1 1,541.6 233.6 21.6 21.4 24.7 5.0
178.5 9,353.6 1,526.9 -151.5 20.0 -17.1 46.8 13.0
326.0 13,067.9 1,403.7 177.7 14.7 13.8 73.7 9.1
117.4 6,632.6 738.3 48.9 11.4 2.4 136.7 3.2
31.1 13,623.0 6,178.4 626.5 13.0 11.9 22.3 2.6

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About AmerisourceBergen (ABC)

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and...  related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.  Read more

Edit peer-selector-edit
loading...
loading...

FAQs for AmerisourceBergen (ABC)

The share price of AmerisourceBergen (ABC) is $179.97 (NYSE) as of 29-Sep-2023 09:30 EDT. AmerisourceBergen (ABC) has given a return of 22.63% in the last 3 years.

The P/E ratio of AmerisourceBergen (ABC) is 21.92 times as on 29-Sep-2023, a 53 discount to its peers’ median range of 46.76 times.
The P/B ratio of AmerisourceBergen (ABC) is 5.58 times as on 29-Sep-2023, a 72 premium to its peers’ median range of 3.24 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
--
--
2021
--
--
2020
--
--
2019
--
--
2018
--
--

The 52-week high and low of AmerisourceBergen (ABC) are Rs -- and Rs -- as of 29-Apr-2026.

AmerisourceBergen (ABC) has a market capitalisation of $ 36,150 Mln as on 29-Sep-2023. As per SEBI classification, it is a company.

Before investing in AmerisourceBergen (ABC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.